Untitled design (42)


Exhibition Partner

VGXI, Inc. is a leading contract manufacturer of DNA-based pharmaceuticals with nearly 20 year of experience providing high quality cGMP products to clinical trials worldwide. Uses include DNA vaccines, immunotherapies, and cell and gene therapy applications. The company's continuous, low-shear AIRMIX® lysis technology and optimized purification process provide highly supercoiled plasmid material at concentrations as high as 15 mg/ml while maintaining exceptional purity and DNA quality. Pre-Clinical through GMP RNA manufacturing services are also available.